Core Scientific (CORZ) Invested Capital (2020 - 2026)

Core Scientific (CORZ) has 7 years of Invested Capital data on file, last reported at -$220.7 million in Q1 2026.

• Quarterly Invested Capital rose 28.27% year-over-year to -$220.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$220.7 million (up 28.27% YoY) and the FY2025 annual result came in at -$962.7 million, down 2.27% from the prior year.
• Invested Capital climbed to -$220.7 million in Q1 2026 per CORZ's latest filing, from -$962.7 million in the prior quarter.
• The five-year high for Invested Capital was $1.2 billion in Q1 2022, with the low at -$1.3 billion in Q3 2025.
• Average Invested Capital over 5 years is -$445.5 million, with a median of -$397.5 million recorded in 2023.
• Year-over-year, Invested Capital soared 912.69% in 2022 and tumbled 348.5% in 2023.
• Core Scientific's Invested Capital stood at -$409.3 million in 2022, then slumped by 32.27% to -$541.4 million in 2023, then plunged by 73.87% to -$941.4 million in 2024, then fell by 2.27% to -$962.7 million in 2025, then soared by 77.08% to -$220.7 million in 2026.
• Business Quant data shows CORZ's Invested Capital at -$220.7 million in Q1 2026, -$962.7 million in Q4 2025, and -$1.3 billion in Q3 2025.